{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:07:22Z","timestamp":1778753242268,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40123-026-01373-6","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:04:15Z","timestamp":1775923455000},"page":"1773-1787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experts Perspectives on Current Practices and Challenges of Diagnosis and Treatment of Dry Eye Disease across Europe and Central Asia"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0289","authenticated-orcid":false,"given":"Giuseppe","family":"Giannaccare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Wyl\u0119ga\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jind\u0159i\u0161ka","family":"Betkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarina","family":"Beisenbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Deryapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iren Izabella","family":"Gabos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Grupcheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Anisia-Iuliana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralitsa","family":"Kermedchieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Majtanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Mrukwa-Kominek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazokat","family":"Mukhamedova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Vitovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Wyl\u0119ga\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16468.1","volume":"7","author":"S Aggarwal","year":"2018","unstructured":"Aggarwal S, Galor A. What\u2019s new in dry eye disease diagnosis? Current advances and challenges. F1000Res. 2018;7:F1000 Faculty Rev-1952. https:\/\/doi.org\/10.12688\/f1000research.16468.1.","journal-title":"F1000Res"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","volume":"279","author":"JS Wolffsohn","year":"2025","unstructured":"Wolffsohn JS, Ben\u00edtez-Del-Castillo JM, Loya-Garcia D, et\u00a0al. TFOS DEWS III: diagnostic methodology. Am J Ophthalmol. 2025;279:387\u2013450. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.033.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1373_CR3","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1177\/11206721221141481","volume":"33","author":"EM Messmer","year":"2023","unstructured":"Messmer EM, Ahmad S, Benitez Del Castillo JM, et\u00a0al. A panel of European dry eye disease experts. Management of inflammation in dry eye disease: recommendations from a European panel of experts. Eur J Ophthalmol. 2023;33(3):1294\u2013307. https:\/\/doi.org\/10.1177\/11206721221141481.","journal-title":"Eur J Ophthalmol."},{"issue":"6","key":"1373_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/ceo.14119","volume":"50","author":"I Brahim","year":"2022","unstructured":"Brahim I, Lamard M, Benyoussef AA, Quellec G. Automation of dry eye disease quantitative assessment: a review. Clin Exp Ophthalmol. 2022;50(6):653\u201366. https:\/\/doi.org\/10.1111\/ceo.14119.","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"1373_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","volume":"31","author":"MA Lemp","year":"2012","unstructured":"Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based cohort: a retrospective study. Cornea. 2012;31(5):472\u20138. https:\/\/doi.org\/10.1097\/ICO.0b013e318225415a.","journal-title":"Cornea"},{"key":"1373_CR6","first-page":"6","volume":"92","author":"A Heiligenhaus","year":"1995","unstructured":"Heiligenhaus A, Koch JM, Kruse FE, Schwarz C, Waubke TN. Diagnosis and and differentiation of dry eye disorders]. Diagnostik und Differenzierung von Benetzungsst\u00f6rungen. Ophthalmologe. 1995;92:6\u201311.","journal-title":"Ophthalmologe"},{"issue":"7","key":"1373_CR7","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1167\/iovs.09-4445","volume":"51","author":"L Tong","year":"2010","unstructured":"Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Investig Ophthalmol Vis Sci. 2010;51(7):3449\u201354. https:\/\/doi.org\/10.1167\/iovs.09-4445.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"1373_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/j.jcrs.0000000000000844","volume":"48","author":"K Donaldson","year":"2022","unstructured":"Donaldson K, Parkhurst G, Saenz B, Whitley W, Williamson B, Hovanesian J. Call to action: treating dry eye disease and setting the foundation for successful surgery. J Cataract Refract Surg. 2022;48(5):623\u20139. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000844.","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"1373_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3238\/arztebl.2015.0071","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71\u201381. https:\/\/doi.org\/10.3238\/arztebl.2015.0071. (quiz 82).","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1373_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, et\u00a0al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003.","journal-title":"Ocul Surf"},{"issue":"4","key":"1373_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ajo.2013.05.040","volume":"156","author":"M Uchino","year":"2013","unstructured":"Uchino M, Yokoi N, Uchino Y, et\u00a0al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol. 2013;156(4):759\u201366. https:\/\/doi.org\/10.1016\/j.ajo.2013.05.040.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1373_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajo.2013.10.014","volume":"157","author":"M Uchino","year":"2014","unstructured":"Uchino M, Uchino Y, Dogru M, et\u00a0al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157(2):294\u2013300. https:\/\/doi.org\/10.1016\/j.ajo.2013.10.014.","journal-title":"Am J Ophthalmol"},{"key":"1373_CR13","doi-asserted-by":"publisher","unstructured":"(2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5(2):75\u201392. https:\/\/doi.org\/10.1016\/s1542-0124(12)70081-2.","DOI":"10.1016\/s1542-0124(12)70081-2"},{"issue":"1","key":"1373_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/OPX.0b013e3182780dbb","volume":"90","author":"WH Ridder 3rd","year":"2013","unstructured":"Ridder WH 3rd, Zhang Y, Huang JF. Evaluation of reading speed and contrast sensitivity in dry eye disease. Optom Vis Sci. 2013;90(1):37\u201344. https:\/\/doi.org\/10.1097\/OPX.0b013e3182780dbb.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"1373_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajo.2013.02.019","volume":"156","author":"N Deschamps","year":"2013","unstructured":"Deschamps N, Ricaud X, Rabut G, Labb\u00e9 A, Baudouin C, Denoyer A. The impact of dry eye disease on visual performance while driving. Am J Ophthalmol. 2013;156(1):184-189.e3. https:\/\/doi.org\/10.1016\/j.ajo.2013.02.019.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0161-6420(99)00513-8","volume":"106","author":"Z Liu","year":"1999","unstructured":"Liu Z, Pflugfelder SC. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology. 1999;106(5):939\u201343. https:\/\/doi.org\/10.1016\/S0161-6420(99)00513-8.","journal-title":"Ophthalmology"},{"issue":"3","key":"1373_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovi\u0107","year":"2007","unstructured":"Miljanovi\u0107 B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2006.11.060.","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 2","key":"1373_CR18","doi-asserted-by":"publisher","first-page":"S404","DOI":"10.1097\/ICL.0000000000000550","volume":"44","author":"K Asiedu","year":"2018","unstructured":"Asiedu K, Dzasimatu SK, Kyei S. Impact of dry eye on psychosomatic symptoms and quality of life in a healthy youthful clinical sample. Eye Contact Lens. 2018;44(Suppl 2):S404\u20139. https:\/\/doi.org\/10.1097\/ICL.0000000000000550.","journal-title":"Eye Contact Lens"},{"issue":"8","key":"1373_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202132","volume":"13","author":"JB Jonas","year":"2018","unstructured":"Jonas JB, Wei WB, Xu L, Rietschel M, Streit F, Wang YX. Self-rated depression and eye diseases: the Beijing Eye Study. PLoS ONE. 2018;13(8):e0202132. https:\/\/doi.org\/10.1371\/journal.pone.0202132.","journal-title":"PLoS ONE"},{"issue":"8","key":"1373_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/bjophthalmol-2014-306481","volume":"99","author":"A Galor","year":"2015","unstructured":"Galor A, Felix ER, Feuer W, et\u00a0al. Dry eye symptoms align more closely to non-ocular conditions than to tear film parameters. Br J Ophthalmol. 2015;99(8):1126\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306481.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1373_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123299","volume":"10","author":"M Kawashima","year":"2015","unstructured":"Kawashima M, Uchino M, Yokoi N, et\u00a0al. Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study. PLoS ONE. 2015;10(4):e0123299. https:\/\/doi.org\/10.1371\/journal.pone.0123299.","journal-title":"PLoS ONE"},{"issue":"9","key":"1373_CR22","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1167\/iovs.11-9094","volume":"53","author":"M Li","year":"2012","unstructured":"Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Investig Ophthalmol Vis Sci. 2012;53(9):5722\u20137. https:\/\/doi.org\/10.1167\/iovs.11-9094.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"1373_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/bjophthalmol-2013-303838","volume":"97","author":"A Labb\u00e9","year":"2013","unstructured":"Labb\u00e9 A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol. 2013;97(11):1399\u2013403. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-303838.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","volume":"157","author":"AJ Paulsen","year":"2014","unstructured":"Paulsen AJ, Cruickshanks KJ, Fischer ME, et\u00a0al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799\u2013806. https:\/\/doi.org\/10.1016\/j.ajo.2013.12.023.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1373_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199131","volume":"13","author":"SB Um","year":"2018","unstructured":"Um SB, Yeom H, Kim NH, Kim HC, Lee HK, Suh I. Association between dry eye symptoms and suicidal ideation in a Korean adult population. PLoS ONE. 2018;13(6):e0199131. https:\/\/doi.org\/10.1371\/journal.pone.0199131.","journal-title":"PLoS ONE"},{"issue":"3","key":"1373_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030460","volume":"61","author":"J Kwon","year":"2025","unstructured":"Kwon J, Moghtader A, Kang C, et\u00a0al. Overview of dry eye disease for primary care physicians. Medicina (Kaunas). 2025;61(3):460. https:\/\/doi.org\/10.3390\/medicina61030460.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"1373_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03565-9","volume":"24","author":"CC Sun","year":"2024","unstructured":"Sun CC, Hsu SL, Liang CM, Tsai YY, Lin PY. Bridging the gap in managing dry eye disease: a consensus report by the Taiwan Society of Cataract and Refractive Surgeons. BMC Ophthalmol. 2024;24(1):314. https:\/\/doi.org\/10.1186\/s12886-024-03565-9.","journal-title":"BMC Ophthalmol"},{"key":"1373_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114582","volume":"191","author":"N Nagai","year":"2022","unstructured":"Nagai N, Otake H. Novel drug delivery systems for the management of dry eye. Adv Drug Deliv Rev. 2022;191:114582. https:\/\/doi.org\/10.1016\/j.addr.2022.114582.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1373_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20021313","volume":"20","author":"D Wr\u00f3bel-Dudzi\u0144ska","year":"2023","unstructured":"Wr\u00f3bel-Dudzi\u0144ska D, Osial N, St\u0119pie\u0144 PW, Gorecka A, \u017barnowski T. Prevalence of dry eye symptoms and associated risk factors among university students in Poland. Int J Environ Res Public Health. 2023;20(2):1313. https:\/\/doi.org\/10.3390\/ijerph20021313.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"1373_CR30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30981","volume":"14","author":"BA Almohammed","year":"2022","unstructured":"Almohammed BA, Alnafeesah AA, Aldharman SS, et\u00a0al. Prevalence and severity of dry eye disease symptoms among diabetics: a nationwide survey. Cureus. 2022;14(11):e30981. https:\/\/doi.org\/10.7759\/cureus.30981.","journal-title":"Cureus"},{"issue":"3","key":"1373_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcrs.2015.11.038","volume":"42","author":"DY Maychuk","year":"2016","unstructured":"Maychuk DY, Dry Eye Prevalence Study Group. Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia. J Cataract Refract Surg. 2016;42(3):427\u201334. https:\/\/doi.org\/10.1016\/j.jcrs.2015.11.038.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1373_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/ijo.IJO_698_17","volume":"66","author":"JS Titiyal","year":"2018","unstructured":"Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol. 2018;66(2):207\u201311. https:\/\/doi.org\/10.4103\/ijo.IJO_698_17.","journal-title":"Indian J Ophthalmol"},{"issue":"2 Suppl","key":"1373_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron AJ, Tomlinson A, Foulks GN, et\u00a0al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12(2 Suppl):S1-31. https:\/\/doi.org\/10.1016\/j.jtos.2014.02.002.","journal-title":"Ocul Surf"},{"issue":"Suppl 1(Suppl 1","key":"1373_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","volume":"27","author":"MS Milner","year":"2017","unstructured":"Milner MS, Beckman KA, Luchs JI, et\u00a0al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders\u2014New strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27(Suppl 1(Suppl 1)):3\u201347. https:\/\/doi.org\/10.1097\/01.icu.0000512373.81749.b7.","journal-title":"Curr Opin Ophthalmol"},{"key":"1373_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","volume":"15","author":"GD Novack","year":"2017","unstructured":"Novack GD, Asbell P, Barabino S, et\u00a0al. TFOS DEWS II clinical trial design report. Ocul Surf. 2017;15:629\u201349. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.009.","journal-title":"Ocul Surf"},{"key":"1373_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jtos.2018.05.001","volume":"16","author":"J Pinto-Fraga","year":"2018","unstructured":"Pinto-Fraga J, Enriquez-de-Salamanca A, Calonge M, et\u00a0al. Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a phase III clinical trial. Ocul Surf. 2018;16:368\u201376. https:\/\/doi.org\/10.1016\/j.jtos.2018.05.001.","journal-title":"Ocul Surf"},{"key":"1373_CR37","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1167\/iovs.10-5390","volume":"51","author":"BD Sullivan","year":"2010","unstructured":"Sullivan BD, Whitmer D, Nichols KK, et\u00a0al. An objective approach to dry eye disease severity. Investig Ophthalmol Vis Sci. 2010;51:6125\u201330. https:\/\/doi.org\/10.1167\/iovs.10-5390.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"1373_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/s1542-0124(12)70083-6","volume":"5","author":"AJ Bron","year":"2007","unstructured":"Bron AJ, Abelson MB, Ousler G, et\u00a0al. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):108\u201352. https:\/\/doi.org\/10.1016\/s1542-0124(12)70083-6.","journal-title":"Ocul Surf"},{"key":"1373_CR39","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/OPTH.S258983","volume":"14","author":"AT Epitropoulos","year":"2020","unstructured":"Epitropoulos AT, Therattil A, Periman LM, et\u00a0al. Improving tolerance and compliance with topical immunomodulators using micro-emulsion lipid layer artificial tears. Clin Ophthalmol. 2020;14:1921\u20139. https:\/\/doi.org\/10.2147\/OPTH.S258983.","journal-title":"Clin Ophthalmol"},{"key":"1373_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/a-1115-4756","volume":"237","author":"U Pleyer","year":"2020","unstructured":"Pleyer U, Geerling G, Schrader S, et\u00a0al. If artificial tears aren\u2019t enough. The importance of inflammatory processes in dry eye disease. Practical aspects of an anti-inflammatory therapy of dry eye disease. Klin Monbl Augenheilkd. 2020;237:655\u201368. https:\/\/doi.org\/10.1055\/a-1115-4756. (German).","journal-title":"Klin Monbl Augenheilkd"},{"key":"1373_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/ICO.0b013e31818c69ef","volume":"31","author":"YJ Byun","year":"2012","unstructured":"Byun YJ, Kim TI, Kwon SM, et\u00a0al. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye. Cornea. 2012;31:509\u201313. https:\/\/doi.org\/10.1097\/ICO.0b013e31818c69ef.","journal-title":"Cornea"},{"key":"1373_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ICL.0000000000000049","volume":"40","author":"JD Sheppard","year":"2014","unstructured":"Sheppard JD, Donnenfeld ED, Holland EJ, et\u00a0al. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014;40:289\u201396. https:\/\/doi.org\/10.1097\/ICL.0000000000000049.","journal-title":"Eye Contact Lens"},{"key":"1373_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/tjo.tjo_15_18","volume":"9","author":"S Singla","year":"2019","unstructured":"Singla S, Sarkar L, Joshi M. Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: a prospective study. Taiwan J Ophthalmol. 2019;9:173\u20138. https:\/\/doi.org\/10.4103\/tjo.tjo_15_18.","journal-title":"Taiwan J Ophthalmol"},{"key":"1373_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et\u00a0al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575\u2013628. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006.","journal-title":"Ocul Surf"},{"issue":"4","key":"1373_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/vision4040043","volume":"4","author":"Z Ashena","year":"2020","unstructured":"Ashena Z, Dashputra R, Nanavaty MA. Autoimmune dry eye without significant ocular surface co-morbidities and mental health. Vision (Basel). 2020;4(4):43. https:\/\/doi.org\/10.3390\/vision4040043.","journal-title":"Vision (Basel)"},{"key":"1373_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2147\/CIA.S137580","volume":"12","author":"SB Han","year":"2017","unstructured":"Han SB, Yang HK, Hyon JY, Wee WR. Association of dry eye disease with psychiatric or neurological disorders in elderly patients. Clin Interv Aging. 2017;12:785\u201392. https:\/\/doi.org\/10.2147\/CIA.S137580.","journal-title":"Clin Interv Aging"},{"issue":"5","key":"1373_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.reumae.2025.501891","volume":"21","author":"RE Ruiz-Lozano","year":"2025","unstructured":"Ruiz-Lozano RE, Prida-Espaillat LA, Moll-Auais RA, et\u00a0al. Ocular inflammatory manifestations in patients with rheumatoid arthritis. Reumatol Cl\u00edn (Engl Ed). 2025;21(5):501891. https:\/\/doi.org\/10.1016\/j.reumae.2025.501891.","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"issue":"3","key":"1373_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.31138\/mjr.29.3.127","volume":"29","author":"S Ziaragkali","year":"2018","unstructured":"Ziaragkali S, Kotsalidou A, Trakos N. Dry eye disease in routine rheumatology practice. Mediterr J Rheumatol. 2018;29(3):127\u201339. https:\/\/doi.org\/10.31138\/mjr.29.3.127.","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"1373_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-02959-5","volume":"23","author":"Y Ren","year":"2023","unstructured":"Ren Y, Tian J, Shi W, et\u00a0al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23(1):229. https:\/\/doi.org\/10.1186\/s12886-023-02959-5.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"1373_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050724","volume":"13","author":"H Shan","year":"2023","unstructured":"Shan H, Liu W, Li Y, Pang K. The autoimmune rheumatic disease related dry eye and its association with retinopathy. Biomolecules. 2023;13(5):724. https:\/\/doi.org\/10.3390\/biom13050724.","journal-title":"Biomolecules"},{"issue":"2","key":"1373_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20021584","volume":"20","author":"SC Lai","year":"2023","unstructured":"Lai SC, Wang CW, Wu YM, et\u00a0al. Rheumatoid arthritis associated with dry eye disease and corneal surface damage: a nationwide matched cohort study. Int J Environ Res Public Health. 2023;20(2):1584. https:\/\/doi.org\/10.3390\/ijerph20021584.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"1373_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","volume":"19","author":"GE Thorlacius","year":"2023","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M. Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat Rev Rheumatol. 2023;19(5):288\u2013306. https:\/\/doi.org\/10.1038\/s41584-023-00932-6.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1373_CR53","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1177\/11206721211060963","volume":"32","author":"A Basilious","year":"2022","unstructured":"Basilious A, Xu CY, Malvankar-Mehta MS. Dry eye disease and psychiatric disorders: a systematic review and meta-analysis. Eur J Ophthalmol. 2022;32(4):1872\u201389. https:\/\/doi.org\/10.1177\/11206721211060963.","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"1373_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072040","volume":"9","author":"M Kawashima","year":"2020","unstructured":"Kawashima M, Yamada M, Shigeyasu C, For The Decs-J FTD, et\u00a0al. Association of systemic comorbidities with dry eye disease. J Clin Med. 2020;9(7):2040. https:\/\/doi.org\/10.3390\/jcm9072040.","journal-title":"J Clin Med"},{"issue":"21","key":"1373_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216437","volume":"11","author":"P Aragona","year":"2022","unstructured":"Aragona P, Giannaccare G, Mencucci R, et\u00a0al. The management of dry eye disease: proceedings of Italian dry eye consensus group using the Delphi Method. J Clin Med. 2022;11(21):6437. https:\/\/doi.org\/10.3390\/jcm11216437.","journal-title":"J Clin Med"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01373-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01373-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01373-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:07:14Z","timestamp":1778749634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01373-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01373-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Giuseppe Giannaccare received a publication grant from Santen. Oksana Vitovska received a travel grant to attend an expert meeting. Adam Wyl\u0119ga\u0142a received speaker honoraria from: Oculus, Thea, Santen, Optopol Technology, Lumibird, Centervue, Polpharma. Ewa Mrukwa-Kominek received speaker honoraria from: Thea, Santen, Polpharma, Adamed, Magnapharm, Alcon, Bausch&Lomb. Maria Ma\u015bli\u0144ska received speaker honoraria from Santen. Jind\u0159i\u0161ka Betkov\u00e1 has nothing to disclose. Iryna Deryapa has nothing to disclose. Iren Izabella Gabos has nothing to disclose. Christina Grupcheva has nothing to disclose. Alexa Anisia-Iuliana has nothing to disclose. Ralitsa Kermedchieva has nothing to disclose. Nazokat Mukhamedova has nothing to disclose. Edward Wyl\u0119ga\u0142a has nothing to disclose. Zarina Beisenbayeva has nothing to disclose. Nora Majtanova has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was based solely on expert opinions and did not involve human participants, identifiable patient data, human biological material, or patient images. Accordingly, ethics committee approval was not required. Consent to participate and consent to publish were not applicable. As no human participants or identifiable human materials were involved, Declaration of Helsinki requirements were not applicable. All panelists participating in the study were also authors of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}